Xiaoli Wang

Xiaoli Wang is an experienced professional in clinical pharmacology, currently serving as Executive Director and Head of Clinical Pharmacology at Mersana Therapeutics since 2023. Previously, Xiaoli held the position of Head of Clinical Pharmacology and Quantitative Sciences at Nektar Therapeutics from 2021 to 2023. Prior roles include work in clinical pharmacology for Novartis and BMS, as well as experience at Pfizer and PRA Health Sciences. Xiaoli was also an Executive Committee Member at the Sino-American Pharmaceutical Professionals Association from 2013 to 2015. Educational qualifications include a Ph.D. in Pharmaceutical Sciences from the University of Florida and an MBA from Rutgers University.